Journal of Pain and Symptom Management
Volume 36, Issue 4 , Pages 383-395 , October 2008

Introduction of a Self-Report Version of the Prescription Drug Use Questionnaire and Relationship to Medication Agreement Noncompliance

  • Peggy A. Compton, RN, PhD

      Affiliations

    • Acute Care Section, School of Nursing at UCLA, Los Angeles, California, USA
    • Corresponding Author InformationAddress correspondence to: Peggy Compton, RN, PhD, School of Nursing, University of California at Los Angeles, Factor Building 4-246, Box 956918, Los Angeles, CA 90095-6918, USA.
    • ,
  • Stephen M. Wu, PhD

      Affiliations

    • Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, California, USA
    • UCLA Center for Neurovisceral Sciences and Women's Health, Los Angeles, California, USA
    • ,
  • Beatrix Schieffer, PhD

      Affiliations

    • Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, California, USA
    • UCLA Center for Neurovisceral Sciences and Women's Health, Los Angeles, California, USA
    • ,
  • Quynh Pham, MD

      Affiliations

    • Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, California, USA
    • Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
    • ,
  • Bruce D. Naliboff, PhD

      Affiliations

    • Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, California, USA
    • UCLA Center for Neurovisceral Sciences and Women's Health, Los Angeles, California, USA
    • Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA

,Accepted 6 November 2007.

References 

  1. Portenoy RK, Foley KM. Chronic use of opiate analgesics in non-malignant pain: report of 38 cases. Pain. 1986;25:171–186
  2. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opiate agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA. 2005;293:3043–3052
  3. Rowbotham MC, Twilling L, Davies PS, et al. Oral opiate therapy for chronic peripheral and central neuropathic pain. N Engl J Med. 2003;348:1223–1232
  4. Devulder J, Richarz U, Nataraja SH. Impact of long-term use of opiates on quality of life in patients with chronic, non-malignant pain. Curr Med Res Opin. 2005;21:1555–1568
  5. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opiates in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372–380
  6. Hermann M, Ruschitzka F. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk. Intern Med J. 2006;36:308–319
  7. Dasgupta N, Kramer ED, Zalman MA, et al. Association between non-medical and prescriptive usage of opiates. Drug Alcohol Depend. 2006;82:135–142
  8. Eisenberg E, McNicol E, Carr DB. Opiates for neuropathic pain. Cochrane Database Syst Rev. 2006;3:CD006146
  9. Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: opiate treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146:116–127
  10. American Psychiatric Association . Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed.. Washington, DC: American Psychiatric Association; 2000;
  11. Ballantyne JC, Mao J. Opiate therapy for chronic pain. N Engl J Med. 2003;349:1943–1953
  12. Ballantyne JC, La Forge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain. 2007;129:235–255
  13. Kirsh KL, Whitcomb LA, Donaghy k, Passik SD. Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study. Clin J Pain. 2002;18:S52–S60
  14. Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and “problematic” substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage. 1998;16:355–363
  15. Dunbar SA, Katz NP. Chronic opiate therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases. J Pain Symptom Manage. 1996;11:163–171
  16. Weissman DE, Haddox JD. Opioid pseudoaddiction—an iatrogenic syndrome. Pain. 1989;36:363–366
  17. Sees KL, Clark HW. Opioid use in the treatment of chronic pain: assessment of addiction. J Pain Symptom Manage. 1993;8(5):257–264
  18. Adams LL, Gatchel RJ, Robinson RC, et al. Development of a self-report screening instrument for assessing potential opiate medication misuse in chronic pain patients. J Pain Symptom Manage. 2004;27:440–459
  19. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opiate assessment measure for patients with chronic pain. Pain. 2004;112:65–75
  20. Manchikanti L, Pampati V, Damron KS, McManus CD. Evaluation of variables in illicit drug use: does a controlled substance abuse screening tool identify illicit drug use?. Pain Physician. 2004;7:71–75
  21. Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opiate Misuse Measure. Pain. 2007;130:144–156
  22. Wu SM, Compton P, Bolus R, et al. The addiction behaviors checklist: validation of a new clinician-based measure of inappropriate opiate use in chronic pain. J Pain Symptom Manage. 2006;32:342–351
  23. Burchman SL, Pagel PS. Implementation of a formal treatment agreement for outpatient management of chronic nonmalignant pain with opiate analgesics. J Pain Symptom Manage. 1995;10:556–563
  24. Doleys DM, Rickman L. Other benefits of an opiate “agreement. J Pain Symptom Manage. 2003;25:402–403author reply 403–404
  25. Fishman SM, Bandman TB, Edwards A, Borsook D. The opiate contract in the management of chronic pain. J Pain Symptom Manage. 1999;18:27–37
  26. Hariharan J, Lamb GC, Neuner JM. Long-term opiate contract use for chronic pain management in primary care practice. A five year experience. J Gen Intern Med. 2007;22:485–490
  27. Katz NP, Adams EH, Benneyan JC, et al. Foundations of opiate risk management. Clin J Pain. 2007;23:103–118
  28. Passik SD, Kirsh KL. Opiate therapy in patients with a history of substance abuse. CNS Drugs. 2004;18:13–25
  29. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV, Axis I disorders, clinician version (SCID-CV). Washington, DC: American Psychiatric Press, Inc.; 1996;
  30. Carroll BT, Kathol RG, Noyes R, Wald TG, Clamon GH. Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen Hosp Psychiatry. 1993;15:69–74
  31. Clarke DM, Smith GC, Herrman HE. A comparative study of screening instruments for mental disorders in general hospital patients. Int J Psychiatry Med. 1993;23:323–337
  32. Davidson M, Keating JL. A comparison of five low back disability questionnaires: reliability and responsiveness. Phys Ther. 2002;82:8–24
  33. Fairbank JC, Couper J, Davies JB, O'Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy. 1980;66:271–273
  34. Kahan M, Srivastava A, Wilson L, Gourlay D, Midmer D. Misuse of and dependence on opiates: study of chronic pain patients. Can Fam Physician. 2006;52:1081–1087
  35. Lusher J, Elander J, Bevan D, Telfer P, Burton B. Analgesic addiction and pseudoaddiction in painful chronic illness. Clin J Pain. 2006;22:316–324
  36. Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain. 2002;18:S28–S38
  37. American Academy of Pain Medicine, American Pain Society, American Society of Addiction Medicine . Consensus statement: Definitions related to the use of opiates in the treatment of pain. Glenview, IL: AAPM/APS, and Chevy Chase; 2001;MD: ASAM
  38. Zimmerman M, Coryell W, Wilson S, Corenthal C. Evaluation of symptoms of major depressive disorder. Self-report vs. clinician ratings. J Nerv Ment Dis. 1986;174:150–153
  39. Stacy M, Bowron A, Guttman M, et al. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment. Mov Disord. 2005;20:726–733
  40. Turk DC, Dworkin RH, Allen RR, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003;106:337–345
  41. Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med. 2000;160:853–860
  42. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50:1837–1841
  43. Leslie DL, Rosenheck RA. Inpatient treatment of comorbid psychiatric and substance abuse disorders: comparison of public sector and privately uninsured populations. Adm Policy Ment Health. 1999;26:253–268

 This work was supported by VA Health Services Research and Development.

PII: S0885-3924(08)00202-9

doi: 10.1016/j.jpainsymman.2007.11.006

Journal of Pain and Symptom Management
Volume 36, Issue 4 , Pages 383-395 , October 2008

Article Tools

* Image Usage & Resolution